Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer
/in Dendritic Cells, Exosome, International Publications, Pancreatic Cancer /von 2017-04-20 / Oncoimmunology 2017;6(6):e1319044Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2017-04-07 / J Hematol Oncol 2017 04;10(1):82Immunotherapy in pancreatic cancer treatment: a new frontier
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2016-10-17 / Therap Adv Gastroenterol 2017 Jan;10(1):168-194A feasibility and safety study of vaccination with Poly-ICLC and peptide-pulsed dendritic cells in patients with advanced pancreatic adenocarcinoma.
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2016-06-03 / J Clin Oncol 34, 2016 (suppl; abstr e14579)Dendritic cell vaccine transduced with ubiquitin-mesothelin fusion gene for pancreatic cancer.
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2016-06-03 / J Clin Oncol 34, 2016 (suppl; abstr e14586)Cetuximab delivery and antitumor effects are enhanced by mild hyperthermia in a xenograft mouse model of pancreatic cancer
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2016-03-04 / Cancer Sci. 2016 Apr;107(4):514-20Viro-immune therapy: A new strategy for treatment of pancreatic cancer
/in International Publications, Newcastle Disease Virus, Pancreatic Cancer /von 2016-01-14 / World J. Gastroenterol. 2016 Jan;22(2):748-63Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model
/in International Publications, Newcastle Disease Virus, Pancreatic Cancer /von 2015-12-16 / Mol. Cancer 2015 Dec;14:210Pancreatic adenocarcinoma upregulated factor serves as adjuvant by activating dendritic cells through stimulation of TLR4
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2015-09-29 / Oncotarget 2015 Sep;6(29):27751-62
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de